Clinical Features Associated With an Asp380His Myocilin Mutation in a US Family With Primary Open-Angle Glaucoma

American Journal of Ophthalmology

Volumn 144, Issue 1, 2007, Pages

  Wirtz, Mary K ^a   Samples, John R ^a   Choi, Dongseok ^b   Gaudette, N Donna ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ASPARAGINE; DNA; GLUTAMIC ACID; GLYCINE; HISTIDINE; LEUCINE; MYOCILIN; PROLINE DERIVATIVE;

ADULT; ARTICLE; BASE PAIRING; BLOOD SAMPLING; CASE STUDY; CLINICAL FEATURE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FAMILY; HEALTH; HUMAN; INSTITUTIONAL REVIEW; INTRAOCULAR PRESSURE; MEDICAL ETHICS; MEDICAL RECORD; MUTATION; OBSERVATIONAL STUDY; OPEN ANGLE GLAUCOMA; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN VARIANT; SAMPLE; SCIENCE; SCREENING; TRABECULECTOMY; UNITED STATES; UNIVERSITY;

EID: 34250777931     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.03.037     Document Type: Article

References (52)

1. Quigley H.A., and Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90 (2006) 262-267
2. Wiggs J.L., Allingham R.R., Vollrath D., et al. Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma. Am J Hum Genet 63 (1998) 1549-1552
3. Fingert J.H., Stone E.M., Sheffield V.C., and Alward W.L. Myocilin glaucoma. Surv Ophthalmol 47 (2002) 547-561
4. Gong G., Kosoko-Lasaki O., Haynatzki G.R., and Wilson M.R. Genetic dissection of myocilin glaucoma. Hum Mol Genet 13 (2004) R91-R102
5. Kennan A.M., Mansergh F.C., Fingert J.H., et al. A novel Asp380Ala mutation in the GLC1A/myocilin gene in a family with juvenile onset primary open-angle glaucoma. J Med Genet 35 (1998) 957-960
6. Stoilova D., Child A., Brice G., et al. Novel TIGR/MYOC mutations in families with juvenile onset primary open-angle glaucoma. J Med Genet 35 (1998) 989-992
7. Alward W.L., Fingert J.H., Coote M.A., et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med 338 (1998) 1022-1027
8. Challa P., Herndon L.W., Hauser M.A., et al. Prevalence of myocilin mutations in adults with primary open-angle glaucoma in Ghana, West Africa. J Glaucoma 11 (2002) 416-420
9. Nguyen T.D., Chen P., Huang W.D., et al. Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem 273 (1998) 6341-6350
10. Kubota R., Noda S., Wang Y., et al. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics 41 (1997) 360-369
11. Stamer W.D., Roberts B.C., Howell D.N., and Epstein D.L. Isolation, culture, and characterization of endothelial cells from Schlemm's canal. Invest Ophthalmol Vis Sci 39 (1998) 1804-1812
12. Hardy K.M., Hoffman E.A., Gonzalez P., et al. Extracellular trafficking of myocilin in human trabecular meshwork cells. J Biol Chem 280 (2005) 28917-28926
13. Aroca-Aguilar J.D., Sanchez-Sanchez F., Ghosh S., et al. Myocilin mutations causing glaucoma inhibit the intracellular endoproteolyptic cleavage of myocilin between amino acids Arg226 and Ile227. J Biol Chem 280 (2005) 21043-21051
14. Vollrath D., and Liu Y. Temperature sensitive secretion of mutant myocilins. Exp Eye Res 82 (2006) 1030-1036
15. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 714-720 discussion 729-730
16. Wirtz M.K., Samples J.R., Kramer P.L., et al. Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q. Am J Hum Genet 60 (1997) 296-304
17. Shimizu S., Lichter P.R., Johnson A.T., et al. Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma. Am J Ophthalmol 130 (2000) 165-177
18. Suzuki Y., Shirato S., Taniguchi F., et al. Mutations in the TIGR gene in familial primary open-angle glaucoma in Japan. Am J Hum Genet 61 (1997) 1202-1204
19. Craig J.E., Baird P.N., Healey D.L., et al. Evidence for genetic heterogeneity within eight glaucoma families, with the GLC1A Gln368STOP mutation being an important phenotypic modifier. Ophthalmology 108 (2001) 1607-1620
20. Gobeil S., Letartre L., and Raymond V. Functional analysis of the glaucoma-causing TIGR/myocilin protein: Integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion. Exp Eye Res 82 (2006) 1017-1029
21. Weiss K.M. Is there a paradigm shift in genetics?. Lessons from the study of human diseases. Mol Phylogenet Evol 5 (1996) 259-265
22. Eisensmith R.C., Goltsov A.A., O'Neill C., et al. Recurrence of the R408W mutation in the phenylalanine hydroxylase locus in Europeans. Am J Hum Genet 56 (1995) 278-286
23. Adam M.F., Belmouden A., Binisti P., et al. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet 6 (1997) 2091-2097
24. Bruttini M., Longo I., Frezzotti P., et al. Mutations in the myocilin gene in families with primary open-angle glaucoma and juvenile open-angle glaucoma. Arch Ophthalmol 121 (2003) 1034-1038
25. Fan B.J., Leung D.Y., Wang D.Y., et al. Novel myocilin mutation in a Chinese family with juvenile-onset open-angle glaucoma. Arch Ophthalmol 124 (2006) 102-106
26. Fan B.J., Leung Y.F., Pang C.P., et al. [Single nucleotide polymorphisms of the myocilin gene in primary open-angle glaucoma patients]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21 (2004) 70-73
27. Fan B.J., Wang D.Y., Fan D.S., et al. SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open-angle glaucoma patients. Mol Vis 11 (2005) 625-631
28. Faucher M., Anctil J.L., Rodrigue M.A., et al. Founder TIGR/myocilin mutations for glaucoma in the Quebec population. Hum Mol Genet 11 (2002) 2077-2090
29. Fingert J.H., Heon E., Liebmann J.M., et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 8 (1999) 899-905
30. Jansson M., Marknell T., Tomic L., et al. Allelic variants in the MYOC/TIGR gene in patients with primary open-angle, exfoliative glaucoma and unaffected controls. Ophthalmic Genet 24 (2003) 103-110
31. Ikezoe T., Takeuchit S., Komatsu N., et al. Identification of a new GLC1A mutation in a sporadic, primary open-angle glaucoma in Japan. Int J Mol Med 12 (2003) 259-261
32. Ishikawa K., Funayama T., Ohtake Y., et al. Novel MYOC gene mutation, Phe369Leu, in Japanese patients with primary open-angle glaucoma detected by denaturing high-performance liquid chromatography. J Glaucoma 13 (2004) 466-471
33. Kaur K., Reddy A.B., Mukhopadhyay A., et al. Myocilin gene implicated in primary congenital glaucoma. Clin Genet 67 (2005) 335-340
34. Kee C., and Ahn B.H. TIGR gene in primary open-angle glaucoma and steroid-induced glaucoma. Korean J Ophthalmol 11 (1997) 75-78
35. Pang C.P., Leung Y.F., Chua J.K., Baum L., Fan D.S., and Lam D.S. Novel TIGR sequence alteration Val53Ala. Hum Mutat 15 (2000) 122
36. Pang C.P., Leung Y.F., Fan B., et al. TIGR/MYOC gene sequence alterations in individuals with and without primary open-angle glaucoma. Invest Ophthalmol Vis Sci 43 (2002) 3231-3235
37. Michels-Rautenstrauss K., Mardin C., Wakili N., et al. Novel mutations in the MYOC/GLC1A gene in a large group of glaucoma patients. Hum Mutat 20 (2002) 479-480
38. Melki R., Belmouden A., Brezin A., and Garchon H.J. Myocilin analysis by DHPLC in French POAG patients: increased prevalence of Q368X mutation. Hum Mutat 22 (2003) 179
39. Melki R., Idhajji A., Driouiche S., et al. Mutational analysis of the Myocilin gene in patients with primary open-angle glaucoma in Morocco. Ophthalmic Genet 24 (2003) 153-160
40. Rozsa F.W., Shimizu S., Lichter P.R., et al. GLC1A mutations point to regions of potential functional importance on the TIGR/MYOC protein. Mol Vis 4 (1998) 20
41. Kubota R., Mashima Y., Ohtake Y., et al. Novel mutations in the myocilin gene in Japanese glaucoma patients. Hum Mutat 16 (2000) 270
42. Li Z.M., and He X.G. [Study on the gene mutation of TIGR in primary open-angle glaucoma, their relatives and normal controls in Chongqing]. Zhonghua Yan Ke Za Zhi 39 (2003) 457-461
43. Mansergh F.C., Kenna P.F., Ayuso C., et al. Novel mutations in the TIGR gene in early and late onset open-angle glaucoma. Hum Mutat 11 (1998) 244-251
44. Markandaya M., Ramesh T.K., Selvaraju V., et al. Genetic analysis of an Indian family with members affected with juvenile-onset primary open-angle glaucoma. Ophthalmic Genet 25 (2004) 11-23
45. Stoilova D., Child A., Brice G., et al. Identification of a new 'TIGR' mutation in a family with juvenile-onset primary open-angle glaucoma. Ophthalmic Genet 18 (1997) 109-118
46. Stone E.M., Fingert J.H., Alward W.L., et al. Identification of a gene that causes primary open-angle glaucoma. Science 275 (1997) 668-670
47. Vasconcellos J.P., Melo M.B., Costa V.P., et al. Novel mutation in the MYOC gene in primary open-angle glaucoma patients. J Med Genet 37 (2000) 301-303
48. Vincent A.L., Billingsley G., Buys Y., et al. Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am J Hum Genet 70 (2002) 448-460
49. Yokoyama A., Nao-i N., Date Y., et al. Detection of a new TIGR gene mutation in a Japanese family with primary open-angle glaucoma. Jpn J Ophthalmol 43 (1999) 85-88
50. Yoon S.J., Kim H.S., Moon J.I., et al. Mutations of the TIGR/MYOC gene in primary open-angle glaucoma in Korea. Am J Hum Genet 64 (1999) 1775-1778
51. Zimmerman C.C., Lingappa V.R., Richards J.E., et al. A trabecular meshwork glucocorticoid response (TIGR) gene mutation affects translocational processing. Mol Vis 5 (1999) 19-24
52. Vazquez C.M., Herrero O.M., Bastus B.M., and Perez V.D. Mutations in the third exon of the MYOC gene in spanish patients with primary open-angle glaucoma. Ophthalmic Genet 21 (2000) 109-115